We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAn open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.AuthorsMorrow PK; Murthy RK; Ensor JD; Gordon GS; Margolin KA; Elias AD; Urba WJ; Weng DE; Rugo HS; Hortobagyi GNPublicationCancer, 2012, Vol 118, Issue 17, p4098ISSN1097-0142Publication typearticleDOI10.1002/cncr.26730